Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Fast routes to new therapies: what do epilepsy and inflammatory bowel disease have in common?
Nimgaonkar A, Shah SB.
Gastroenterology. 2012 Mar;142(3):670-1. Epub 2012 Jan 24. No abstract available.
Related citations
HLA-Cw*1202-B*5201-DRB1*1502 haplotype increases risk for ulcerative colitis but reduces risk for Crohn's disease.
Asakura H.
Gastroenterology. 2012 Mar;142(3):e27-8; author reply e28-9. Epub 2012 Jan 24. No abstract available.
Inflammatory bowel disease and thromboembolism: a c'lot' to worry about.
Max J, Waljee AK.
Gastroenterology. 2012 Feb;142(2):404-5. Epub 2011 Dec 19. No abstract available.
Adalimumab in ulcerative colitis: can pharmacodynamics be improved based on pharmacokinetics?
Louis E, Panés J.
Gastroenterology. 2012 Jan;142(1):176-8. Epub 2011 Nov 21. No abstract available.
Rituximab in active ulcerative colitis.
Calderón-Gómez E, Panés J.
Gastroenterology. 2012 Jan;142(1):174-6. Epub 2011 Nov 21. No abstract available.
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis.
Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D'Haens G, Wolf DC, Kron M, Tighe MB, Lazar A, Thakkar RB.
Gastroenterology. 2012 Feb;142(2):257-65.e1-3. Epub 2011 Nov 4.
Loss of interleukin-10 or transforming growth factor β signaling in the human colon initiates a T-helper 1 response via distinct pathways.
Jarry A, Bossard C, Sarrabayrouse G, Mosnier JF, Laboisse CL.
Gastroenterology. 2011 Nov;141(5):1887-96.e1-2. Epub 2011 Aug 10.
Cathepsin S is activated during colitis and causes visceral hyperalgesia by a PAR2-dependent mechanism in mice.
Cattaruzza F, Lyo V, Jones E, Pham D, Hawkins J, Kirkwood K, Valdez-Morales E, Ibeakanma C, Vanner SJ, Bogyo M, Bunnett NW.
Gastroenterology. 2011 Nov;141(5):1864-74.e1-3. Epub 2011 Jul 28.
Spontaneous, immune-mediated gastric inflammation in SAMP1/YitFc mice, a model of Crohn's-like gastritis.
Reuter BK, Pastorelli L, Brogi M, Garg RR, McBride JA, Rowlett RM, Arrieta MC, Wang XM, Keller EJ, Feldman SH, Mize JR, Cominelli F, Meddings JB, Pizarro TT.
Gastroenterology. 2011 Nov;141(5):1709-19. Epub 2011 Jun 23.
Impaired integrity of DNA after recovery from inflammation causes persistent dysfunction of colonic smooth muscle.
Choi K, Chen J, Mitra S, Sarna SK.
Gastroenterology. 2011 Oct;141(4):1293-301, 1301.e1-3. Epub 2011 Jul 13.
Thiopurines for inflammatory bowel disease: time to engage with dermatologists?
Jess T.
Gastroenterology. 2011 Nov;141(5):1549-51. Epub 2011 Sep 22. No abstract available.
Genetic profiling in inflammatory bowel disease: from association to bedside.
Van Limbergen J, Philpott D, Griffiths AM.
Gastroenterology. 2011 Nov;141(5):1566-71.e1. Epub 2011 Sep 19. Review. No abstract available.
Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
Kawashima R, Kawamura YI, Oshio T, Son A, Yamazaki M, Hagiwara T, Okada T, Inagaki-Ohara K, Wu P, Szak S, Kawamura YJ, Konishi F, Miyake O, Yano H, Saito Y, Burkly LC, Dohi T.
Gastroenterology. 2011 Dec;141(6):2119-2129.e8. Epub 2011 Sep 3.
An unusual cause of fibrostenotic terminal ileal disease.
Nasr JY, Lloyd J, Yadav D.
Gastroenterology. 2011 Sep;141(3):e5-6. Epub 2011 Jul 23. No abstract available.
Ultrasound elasticity imaging for detecting intestinal fibrosis and inflammation in rats and humans with Crohn's disease.
Stidham RW, Xu J, Johnson LA, Kim K, Moons DS, McKenna BJ, Rubin JM, Higgins PD.
Gastroenterology. 2011 Sep;141(3):819-826.e1. Epub 2011 Jul 23.
TLE1 modifies the effects of NOD2 in the pathogenesis of Crohn's disease.
Nimmo ER, Stevens C, Phillips AM, Smith A, Drummond HE, Noble CL, Quail M, Davies G, Aldhous MC, Wilson DC, Satsangi J.
Gastroenterology. 2011 Sep;141(3):972-981.e1-2. Epub 2011 May 27.
Plant extract: a natural immune booster for ulcerative colitis.
Shah SB.
Gastroenterology. 2011 Oct;141(4):1525-6. Epub 2011 Aug 24. No abstract available.
The epithelia-specific membrane trafficking factor AP-1B controls gut immune homeostasis in mice.
Takahashi D, Hase K, Kimura S, Nakatsu F, Ohmae M, Mandai Y, Sato T, Date Y, Ebisawa M, Kato T, Obata Y, Fukuda S, Kawamura YI, Dohi T, Katsuno T, Yokosuka O, Waguri S, Ohno H.
Gastroenterology. 2011 Aug;141(2):621-32. Epub 2011 May 5.
Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
Singh H, Nugent Z, Demers AA, Bernstein CN.
Gastroenterology. 2011 Nov;141(5):1612-20. Epub 2011 Jul 30.
Unlocking the gates to inflammatory bowel disease: the role of Enterococcus faecalis gelatinase.
Vedantam G, Viswanathan VK.
Gastroenterology. 2011 Sep;141(3):795-8. Epub 2011 Jul 23. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on